Genus plc (LON:GNS - Get Free Report) shares were up 19.4% during mid-day trading on Wednesday . The stock traded as high as GBX 1,714 ($20.98) and last traded at GBX 1,700.27 ($20.81). Approximately 4,525,729 shares were traded during mid-day trading, an increase of 667% from the average daily volume of 590,108 shares. The stock had previously closed at GBX 1,424 ($17.43).
Analysts Set New Price Targets
Separately, Shore Capital reaffirmed a "buy" rating on shares of Genus in a research note on Wednesday, December 11th.
Read Our Latest Research Report on Genus
Genus Stock Performance
The firm has a market cap of £1.14 billion, a PE ratio of 14,533.33, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37. The company has a 50 day simple moving average of GBX 1,651.46 and a 200-day simple moving average of GBX 1,780.89. The company has a debt-to-equity ratio of 53.54, a current ratio of 1.80 and a quick ratio of 1.08.
About Genus
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Further Reading
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
